Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation

References

• Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet. 2021;397:1577–1590. doi:10.1016/S0140-6736(20)32205-4
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189–a006189. doi:10.1101/cshperspect.a006189
   PubMed Web of Science ®Google Scholar
• Xu W, Tan L, Wang HF, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol. 2015;86:1299–1306.
   Web of Science ®Google Scholar
• Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39:151–170. doi:10.1016/0306-4522(90)90229-W
   PubMed Web of Science ®Google Scholar
• Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009;4:399–418. doi:10.1007/s11481-009-9164-4
   PubMed Web of Science ®Google Scholar
• Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience. 2007;10:1387–1394. doi:10.1038/nn1997
   PubMed Web of Science ®Google Scholar
• Salter MW, Beggs S. Sublime microglia: expanding roles for The Guardians of the CNS. Cell. 2014;158:15–24. doi:10.1016/j.cell.2014.06.008
   PubMed Web of Science ®Google Scholar
• Wendimu MY, Hooks SB. Microglia phenotypes in aging and neurodegenerative diseases. Cells. 2022;11:2091. doi:10.3390/cells11132091
   PubMed Web of Science ®Google Scholar
• Tcw J, Qian L, Pipalia NH, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185:2213–2233.e2225. doi:10.1016/j.cell.2022.05.017
   PubMed Web of Science ®Google Scholar
• Wang S, Sudan R, Peng V, et al. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways. Cell. 2022;185:4153–4169.e4119. doi:10.1016/j.cell.2022.09.033
   PubMed Web of Science ®Google Scholar
• Lopes KP, Snijders GJL, Humphrey J, et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat Genet. 2022;54:4–17. doi:10.1038/s41588-021-00976-y
   PubMed Web of Science ®Google Scholar
• Li Y, Li Z, Yang M, et al. Decoding the temporal and regional specification of microglia in the developing human brain. Cell Stem Cell. 2022;29:e626. doi:10.1016/j.stem.2022.02.004
   Web of Science ®Google Scholar
• Ennerfelt H, Frost EL, Shapiro DA, et al. SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell. 2022;185:e4122. doi:10.1016/j.cell.2022.09.030
   Web of Science ®Google Scholar
• Schafer DP, Lehrman E, Kautzman A, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691–705. doi:10.1016/j.neuron.2012.03.026
   PubMed Web of Science ®Google Scholar
• Herz J, Filiano AJ, Wiltbank AT, Yogev N, Kipnis J. Myeloid cells in the central nervous system. Immunity. 2017;46:943–956. doi:10.1016/j.immuni.2017.06.007
   PubMed Web of Science ®Google Scholar
• Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155:1596–1609. doi:10.1016/j.cell.2013.11.030
   PubMed Web of Science ®Google Scholar
• Madinier A, Bertrand N, Mossiat C, et al. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One. 2009;4:e8101. doi:10.1371/journal.pone.0008101
   PubMed Web of Science ®Google Scholar
• Lue LF, Kuo YM, Beach T, Walker DG. Microglia activation and anti-inflammatory regulation in Alzheimer’s disease. Molecular Neurobiol. 2010;41:115–128. doi:10.1007/s12035-010-8106-8
   PubMed Web of Science ®Google Scholar
• Leyns CEG, Holtzman DM. Glial contributions to neurodegeneration in tauopathies. Molecular Neurodeg. 2017;12:50. doi:10.1186/s13024-017-0192-x
   PubMed Web of Science ®Google Scholar
• Shippy DC, Ulland TK. Microglial immunometabolism in Alzheimer’s disease. Front Cell Neurosci. 2020;14:563446. doi:10.3389/fncel.2020.563446
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432. doi:10.1038/372425a0
   PubMed Web of Science ®Google Scholar
• Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377:530–532. doi:10.1038/377530a0
   PubMed Web of Science ®Google Scholar
• Huang XF, Koutcherov I, Lin S, Wang HQ, Storlien L. Localization of leptin receptor mRNA expression in mouse brain. Neuroreport. 1996;7:2635–2638. doi:10.1097/00001756-199611040-00045
   PubMed Web of Science ®Google Scholar
• Tartaglia LA, Dembski M, Weng X, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83:1263–1271. doi:10.1016/0092-8674(95)90151-5
   PubMed Web of Science ®Google Scholar
• McGregor G, Clements L, Farah A, Irving AJ, Harvey J. Age-dependent regulation of excitatory synaptic transmission at hippocampal temporoammonic-CA1 synapses by leptin. Neurobiology of Aging. 2018;69:76–93. doi:10.1016/j.neurobiolaging.2018.05.007
   PubMed Web of Science ®Google Scholar
• Lilamand M, Bouaziz-Amar E, Dumurgier J, et al. Plasma leptin is associated with amyloid CSF biomarkers and Alzheimer’s disease diagnosis in cognitively impaired patients. The J Gerontol. 2023;78 645–652.
   Google Scholar
• Ha J, Kwak S, Kim KY, et al. Relationship between adipokines, cognition, and brain structures in old age depending on obesity. J Gerontol. 2022.
   Google Scholar
• Hamilton K, Harvey J. The neuronal actions of leptin and the implications for treating Alzheimer’s disease. Pharmaceuticals. 2021;14:1.
   Web of Science ®Google Scholar
• Hamilton K, Harvey J. Leptin regulation of hippocampal synaptic function in health and disease. Vitam Hormon. 2021;115:105–127.
   PubMed Web of Science ®Google Scholar
• King A, Brain A, Hanson K, et al. Disruption of leptin signalling in a mouse model of Alzheimer’s disease. Meta Brain Dis. 2018;33. doi:10.1007/s11011-018-0203-9
   PubMed Web of Science ®Google Scholar
• Fewlass DC, Noboa K, Pi‐Sunyer FX, et al. Obesity-related leptin regulates Alzheimer’s Abeta. FASEB J. 2004;18:1870–1878. doi:10.1096/fj.04-2572com
   PubMed Web of Science ®Google Scholar
• Shinjyo N, Kita K. Infection and immunometabolism in the central nervous system: a possible mechanistic link between metabolic imbalance and dementia. Front Cell Neurosci. 2021;15:765217.
   PubMed Web of Science ®Google Scholar
• Tang CH, Lu D-Y, Yang R-S, et al. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia. J Immunol. 2007;179:1292–1302. doi:10.4049/jimmunol.179.2.1292
   PubMed Web of Science ®Google Scholar
• Pinteaux E, Inoue W, Schmidt L, et al. Leptin induces interleukin-1beta release from rat microglial cells through a caspase 1 independent mechanism. J Neurochem. 2007;102:826–833. doi:10.1111/j.1471-4159.2007.04559.x
   PubMed Web of Science ®Google Scholar
• Chang KT, Lin Y-L, Lin C-T, et al. Leptin is essential for microglial activation and neuropathic pain after preganglionic cervical root avulsion. Life Sci. 2017;187:31–41. doi:10.1016/j.lfs.2017.08.016
   PubMed Web of Science ®Google Scholar
• Benbenishty A, Schneiderman J, Mongin AA. Intraarterial anti-leptin therapy via ICA protects ipsilateral CA1 neurons subjected to ischemia and reperfusion. PLoS One. 2022;17:e0261644. doi:10.1371/journal.pone.0261644
   PubMed Web of Science ®Google Scholar
• Lu L, Fu Z, Wu B, Zhang D, Wang Y. Leptin ameliorates Abeta1-42-induced Alzheimer’s disease by suppressing inflammation via activating p-Akt signaling pathway. Transl Neurosci. 2023;14. doi:10.1515/tnsci-2022-0270
   PubMed Web of Science ®Google Scholar
• Calió ML, Mosini AC, Marinho DS, et al. Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer’s disease. Neurobiol Dis. 2021;148:105219. doi:10.1016/j.nbd.2020.105219
   PubMed Web of Science ®Google Scholar
• Fernandez-Martos CM, Gonzalez P, Rodriguez FJ, Combs C. Acute leptin treatment enhances functional recovery after spinal cord injury. PLoS One. 2012;7:e35594. doi:10.1371/journal.pone.0035594
   PubMed Web of Science ®Google Scholar
• Davis BM, Salinas-Navarro M, Cordeiro MF, Moons L, De Groef L. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep. 2017;7. doi:10.1038/s41598-017-01747-8
   Web of Science ®Google Scholar
• Pérez-González R, Alvira-Botero MX, Robayo O, et al. Leptin gene therapy attenuates neuronal damages evoked by amyloid-β and rescues memory deficits in APP/PS1 mice. Gene Therapy. 2014;21:298–308. doi:10.1038/gt.2013.85
   PubMed Web of Science ®Google Scholar
• Babcock AA, Ilkjær L, Clausen BH, et al. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice. Brain Behav Immunit. 2015;48:86–101. doi:10.1016/j.bbi.2015.03.006
   PubMed Web of Science ®Google Scholar
• Bonda DJ, Stone JG, Torres SL, et al. Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance. J Neurochemist. 2014;128:162–172. doi:10.1111/jnc.12380
   PubMed Web of Science ®Google Scholar
• Takemiya T, Fumizawa K, Yamagata K, Iwakura Y, Kawakami M. Brain interleukin-1 facilitates learning of a water maze spatial memory task in young mice. Front Behav Neurosci. 2017;11. doi:10.3389/fnbeh.2017.00202
   PubMed Web of Science ®Google Scholar
• Del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky HO. A cytokine network involving brain-borne IL-1beta, IL-1ra, IL-18, IL-6, and TNFalpha operates during long-term potentiation and learning. Brain Behav Immu. 2013;33:15–23. doi:10.1016/j.bbi.2013.05.011
   PubMed Web of Science ®Google Scholar
• Balschun D, Wetzel W, Rey A, et al. Interleukin-6: a cytokine to forget. FASEB J. 2004;18:1788–1790. doi:10.1096/fj.04-1625fje
   PubMed Web of Science ®Google Scholar
• Jankowsky JL, Derrick BE, Patterson PH. Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn Mem. 2000;7:400–412. doi:10.1101/lm.32600
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang W, Wang H-F, et al. Peripheral blood adipokines and insulin levels in patients with Alzheimer’s disease: a replication study and meta-analysis. Current Alzheimer Res. 2016;13:223–233. doi:10.2174/156720501303160217111434
   PubMed Web of Science ®Google Scholar
• Lieb W, Beiser AS, Vasan RS, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009;302:2565. doi:10.1001/jama.2009.1836
   PubMed Web of Science ®Google Scholar
• Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks. Horm Metab Res. 1996;28:619–632. doi:10.1055/s-2007-979867
   PubMed Web of Science ®Google Scholar
• Greco SJ, Bryan KJ, Sarkar S, et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer’s disease. J Alzheimer’s Dis. 2010;19:1155–1167.
   PubMed Web of Science ®Google Scholar
• Casado ME, Collado-Perez R, Frago LM, Barrios V. Recent advances in the knowledge of the mechanisms of leptin physiology and actions in neurological and metabolic pathologies. Inter J Molec Sci. 2023;24:1.
   Web of Science ®Google Scholar
• Bivona G, Iemmolo M, Agnello L, et al. Microglial activation and priming in Alzheimer’s disease: state of the art and future perspectives. Inter J Mole Sci. 2023;24:884. doi:10.3390/ijms24010884
   PubMed Web of Science ®Google Scholar
• Michaud JP, Hallé M, Lampron A, et al. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology. Proceed National Acad Sci Unit State Am. 2013;110:1941–1946. doi:10.1073/pnas.1215165110
   PubMed Web of Science ®Google Scholar
• Merighi S, Nigro M, Travagli A, Gessi S. Microglia and Alzheimer’s disease. Inter J Molec Sci. 2022;23:12990. doi:10.3390/ijms232112990
   PubMedGoogle Scholar
• McKee CG, Hoffos M, Vecchiarelli HA, Tremblay ME. Microglia: a pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease. Front Pharmacol. 2023;14. doi:10.3389/fphar.2023.1125982
   PubMed Web of Science ®Google Scholar
• Bagheri-Mohammadi S. Microglia in Alzheimer’s disease: the role of stem cell-microglia interaction in brain homeostasis. Neurochem Res. 2021;46:141–148. doi:10.1007/s11064-020-03162-4
   PubMed Web of Science ®Google Scholar
• Wu YG, Song LJ, Yin LJ, et al. The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease. Neural Regen Res. 2023;18:947–954.
   PubMed Web of Science ®Google Scholar